What's new? Clinical progression and staging of Parkinson's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 70, 2006, Pages 305-308

  Goetz, C G ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

CLINICAL PRACTICE; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; INFORMATION PROCESSING; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; STATISTICAL MODEL; SYMPTOMATOLOGY;

EID: 33750345882     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-45295-0_46     Document Type: Conference Paper

References (10)

1. Chaudhuri R (2004) Can we improve the holistic assessment of Parkinson's disease? ACNR 4: 20-25
2. Fahn S, Elton RL, UPDRS program members (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease, vol 2. Macmillan Healthcare Information, Florham Park, NJ, pp 153-163, 293-304
3. Goetz CG (chair), Bronte-Stewart H, Elble RJ, Hallett M, Kraus PH, Kubuta K, Ramig L, Sanger TD, Stebbins GT, Taylor CB, Wu AD (members in alphabetical order) (2005) Testing objective measures of motor impairment in early Parkinson's disease. Grant in process, underwritten by Kinetics Foundation, Palo Alto, CA, USA
4. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten B (2006) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format and clinimetric testing plan. Mov Disord (in press)
5. Guimaraes P, Kieburtz K, Goetz CG, Elm J, Palesch Y, Hunag P, Tilley B (2005) Non-linearity of Parkinson's disease clinical progression: implications for sample size calculations in clinical trials. Mov Disord 20 [Suppl 10]: S80
6. Jankovic JJ, Tolosa E (eds) (2002) Parkinson's disease and movement disorders. Lippincott, Williams and Wilkins, Philadelphia, PA
7. Kieburtz K (2003) Designing neuroprotection trials in Parkinson's disease. Ann Neurol 53 [Suppl 3]: S100-S107
8. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease: Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Fahn S, Lang AE, Martinez-Martin P, Tilley BC, Van Hilten B (2003) The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18: 738-750
9. Nyholm D, Kowalski J, Aquilonius SM (2004) Wireless readl-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease. Mov Disord 19:446-451
10. Nyholm D, Nilsson Ramahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H (2005) Duodenal levodopa infusion monotherapy vs. oral polypharmacy in advanced Parkinson's disease. Neurology 64: 216-623